Search results for "Methicillin"

showing 10 items of 60 documents

Healthcare-Associated Pneumonia and Multidrug Resistant Bacteria: Do We Have a Convincing Answer?

2014

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtyBacteriabusiness.industryMedicine (all)Drug ResistanceBacterialPneumonia Ventilator-AssociatedBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)Pneumoniamedicine.diseasePneumoniaVentilator-AssociatedMultidrug resistant bacteriaInfectious DiseasesHealthcare associatedEnterobacteriaceaeDrug Resistance BacterialPseudomonas aeruginosamedicineBacteria; Enterobacteriaceae; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Ventilator-Associated; Pseudomonas aeruginosa; Drug Resistance; Bacterial; Infectious Diseases; Microbiology (medical); Medicine (all)HumansIntensive care medicinebusiness
researchProduct

Methicillin-resistant staphylococcus aureus from pressure ulcers in patients receiving home care in Palermo, Italy

2009

Dear Sir,Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent and serious threat to hospitalized patients globally and now represents a challenge for public health, as community-acquire...

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtyHospitalized patientsmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataInternal medicinemedicineHumansIn patientIntensive care medicinePressure UlcerGeneral Immunology and Microbiologybusiness.industryPublic healthGeneral MedicineStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionbacterial infections and mycosesHome Care ServicesMethicillin-resistant Staphylococcus aureusMRSA home care pressure ulcersCommunity-Acquired InfectionsInfectious DiseasesItalyStaphylococcus aureusbusiness
researchProduct

Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, duri…

2012

Abstract Background The evolving epidemiology of methicillin resistant Staphylococcus aureus (MRSA) is characterized by the emergence of infections caused by non multiresistant MRSA carrying staphylococcal chromosomal cassette (SCC)mec IV or V in the healthcare settings. A molecular epidemiological analysis of non multiresistant MRSA isolates from four acute general hospitals was performed in Palermo, Italy, during a one year period. Methods For the purpose of the study, MRSA isolates were defined as non multiresistant when they were susceptible to at least three classes of non β-lactam antibiotics. Seventy-five isolates were submitted to antimicrobial susceptibility testing, multilocus seq…

Methicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtylcsh:QR1-502Microbial Sensitivity TestsDrug resistanceTigecyclineBiologyStaphylococcal infectionsmedicine.disease_causelcsh:MicrobiologyMicrobiologylcsh:Infectious and parasitic diseasesMedical microbiologyDrug Resistance Multiple BacterialmedicineHumanslcsh:RC109-216Researchlcsh:RM1-950General MedicineStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionmedicine.diseasebacterial infections and mycosesMethicillin-resistant Staphylococcus aureusVirologyAnti-Bacterial AgentsInfectious Diseaseslcsh:Therapeutics. PharmacologyItalyMultilocus sequence typingMethicillin ResistanceDaptomycinPanton–Valentine leukocidinSentinel SurveillanceMultilocus Sequence Typingmedicine.drugAnnals of Clinical Microbiology and Antimicrobials
researchProduct

New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens

2013

The synthesis and the in vitro antibacterial activity of novel linezolid-like oxadiazoles are reported. Replacement of the linezolid morpholine C-ring with 1,2,4-oxadiazole results in an antibacterial activity against Staphylococcus aureus both methicillin-susceptible and methicillin-resistant comparable or even superior to that of linezolid. While acetamidomethyl or thioacetoamidomethyl moieties in the C(5) side-chain are required, fluorination of the phenyl B ring exhibits a slight effect on an antibacterial activity but its presence seems to reduce the compounds cytotoxicity. Molecular modeling performed using two different approaches - FLAP and Amber software - shows that in the binding…

Methicillin-Resistant Staphylococcus aureusModels MolecularCell viabilityStaphylococcus aureusMolecular modelCell SurvivalMicrobial Sensitivity TestsAntimicrobial activityCrystallography X-Raymedicine.disease_causeDrug designMicrobiologyStructure-Activity Relationshipchemistry.chemical_compoundoxadiazoles linezolid antibioticsCell Line TumorDrug Resistance Multiple BacterialMorpholineAcetamidesDrug DiscoverymedicineHumansMoietyStructure–activity relationshipOxazolidinonesPharmacologyOxadiazolesOxazolidinones; Linezolid; Drug designDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryLinezolidSettore CHIM/06 - Chimica OrganicaHep G2 CellsGeneral Medicinebiochemical phenomena metabolism and nutritionbacterial infections and mycosesSettore CHIM/08 - Chimica FarmaceuticaMethicillin-resistant Staphylococcus aureusCombinatorial chemistryOxazolidinoneAnti-Bacterial AgentsStaphylococcus aureusMED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICALinezolidAntimicrobial activity; Cell viability; Drug design; Oxazolidinones; Staphylococcus aureusAntibacterial activitySoftware
researchProduct

Novel strategies in the war against antibiotic resistance

2021

The global threat of antibiotic resistance is steadily growing. Antibiotic resistancemay involve any class of antibiotic, including second- and third-line agents that have been considered to date the last-resort drugs to counteract common infections. We may lose our capability to keep under control many common bacterial infections [1]. Despite this, in the past decade significant research efforts have been made to develop new antibacterial strategies able to treat multidrug-resistant infections; however, no new therapeutic approach has yet reached the clinic [2,3]. In order to identify new valuable antimicrobial drugs, it is important to consider the main bacterial resistance mechanisms in …

Methicillin-Resistant Staphylococcus aureusPharmacologyVirulencebiologyChemistryEscherichia coli ProteinsProtein Disulfide-IsomerasesBiofilmDrug Resistance MicrobialAnti-Bacterial AgentsMicrobiologyDsbAAntibiotic resistanceBiofilmsDrug DiscoveryEscherichia colibiology.proteinMolecular Medicineantibiotic resistance antivirulence strategy biofilm DsbA MRSA
researchProduct

Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains.

2014

A series of new heterometallic gold(I) thiolates containing ferrocenyl-phoshines were synthesized. Their antimicrobial properties were studied and compared to that of FDA-approved drug, auranofin (Ridaura), prescribed for the treatment of rheumatoid arthritis. MIC in the order of one digit micromolar were found for most of the compounds against Gram-positive bacteria Staphylococcus aureus and CA MRSA strains US300 and US400. Remarkably, auranofin inhibited S. aureus, US300 and US400 in the order of 150-300 nM. This is the first time that the potent inhibitory effect of auranofin on MRSA strains has been described. The effects of a selected heterometallic compound and auranofin were also stu…

Methicillin-Resistant Staphylococcus aureusStaphylococcus aureusAuranofinMicrobial Sensitivity Testsmedicine.disease_causeCrystallography X-RayBiochemistryArticleMicrobiologyInorganic ChemistryAuranofinmedicineHumansInhibitory effectbiologyChemistryAntimicrobialbiology.organism_classificationMethicillin-resistant Staphylococcus aureusKidney cellAnti-Bacterial AgentsHEK293 CellsStaphylococcus aureusOrganogold CompoundsBacteriamedicine.drugJournal of inorganic biochemistry
researchProduct

Synthesis, characterization, crystal structures and in vitro antistaphylococcal activity of organotin(IV) derivatives with 5,7-disubstituted-1,2,4-tr…

2011

Abstract New organotin(IV) complexes of 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine ( dbtp ) and 5,7-diphenyl-1,2,4-triazolo[1,5-a]pyrimidine ( dptp ) with 1:1 and/or 1:2 stoichiometry were synthesized and investigated by X-ray diffraction, FT-IR and 119 Sn Mossbauer in the solid state and by 1 H and 13 C NMR spectroscopy, in solution. Moreover, the crystal and molecular structures of Et 2 SnCl 2 (dbtp) 2 and Ph 2 SnCl 2 (EtOH) 2 (dptp) 2 are reported. The complexes contain hexacoordinated tin atoms: in Et 2 SnCl 2 (dbtp) 2 two 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine molecules coordinate classically the tin atom through N(3) atom and the coordination around the tin atom shows a …

Methicillin-Resistant Staphylococcus aureusTRIAZOLOPYRIMIDINE ORGANOTIN(IV)Staphylococcus aureusMagnetic Resonance SpectroscopyPyrimidineStereochemistrychemistry.chemical_elementOrganotin(IV)Crystal structureBiochemistryMedicinal chemistryInorganic Chemistrychemistry.chemical_compoundSpectroscopy MossbauerX-Ray DiffractionMössbauer spectroscopySpectroscopy Fourier Transform InfraredEscherichia coliOrganotin CompoundsMoleculeANTIMICROBIAL ACTIVITYTriazolopyrimidine; Organotin(IV); X-ray-structure; 119Sn Mössbauer; Antimicrobial activityCarbon-13 NMRTriazolesAnti-Bacterial AgentsTrigonal bipyramidal molecular geometryPyrimidineschemistryOctahedronSettore CHIM/03 - Chimica Generale E InorganicaPseudomonas aeruginosaTriazolopyrimidine119SN MÖSSBAUERTinX-RAY-STRUCTUREJournal of inorganic biochemistry
researchProduct

Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections

2021

Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as one of the leading causes of persistent human infections. This pathogen is widespread and is able to colonize asymptomatically about a third of the population, causing moderate to severe infections. It is currently considered the most common cause of nosocomial infections and one of the main causes of death in hospitalized patients. Due to its high morbidity and mortality rate and its ability to resist most antibiotics on the market, it has been termed a “superbug”. Its ability to form biofilms on biotic and abiotic surfaces seems to be the primarily means of MRSA antibiotic resistance and pervasiveness. Importantly, more tha…

Methicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classMRSA biofilm antibiotic-resistance antivirulence strategy eradicating agentsAntibioticsPopulationbeta-Lactamsmedicine.disease_cause01 natural sciencesBiochemistryHigh morbidityAntibiotic resistanceDrug Resistance BacterialDrug DiscoveryHumansMedicineGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicineeducationProtein Kinase InhibitorsPathogenOxazolidinonesPharmacologyeducation.field_of_study010405 organic chemistrybusiness.industryMortality rateOrganic ChemistryBiofilmStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionAnti-Bacterial Agents0104 chemical sciences010404 medicinal & biomolecular chemistryStaphylococcus aureusBiofilmsPhenazinesMolecular MedicinebusinessChemMedChem
researchProduct

Prevention of nosocomial infections and surveillance of emerging resistances in NICU

2011

Neonates hospitalized in NICU are at risk for healthcare associated infections because of their poor immune defenses, related to gestational age, colonization of mucous membranes and skin with nosocomial microorganisms, exposure to antibiotics, invasive procedures and frequent contacts with healthcare workers (HCWs). Healthcare associated infections are the major source of morbidity and mortality in NICU in the developed world. Most infections are caused by Gram-positive organisms, fulminant sepsis are often associated to Gram-negative organisms, fungal sepsis occurs frequently in ELBW infants. Hand hygiene is the most important preventive procedure, nevertheless hand hygiene compliance amo…

Methicillin-Resistant Staphylococcus aureusmedicine.medical_specialtymedicine.drug_classprevention surveillance nosocomial infections resistance neonate multidrug resistant organisms methicillin resistant staphylococcus aureusmedia_common.quotation_subjectAntibioticsDrug resistancemedicine.disease_causeCommunicable Diseases EmergingSepsisSettore MED/38 - Pediatria Generale E SpecialisticaHygieneIntensive Care Units NeonatalHumansMedicineIntensive care medicinemedia_commonCross InfectionInfection Controlbusiness.industryTransmission (medicine)Infant NewbornObstetrics and GynecologyDrug Resistance Microbialmedicine.diseaseAntimicrobialMethicillin-resistant Staphylococcus aureusDrug Resistance MultiplePopulation SurveillancePediatrics Perinatology and Child HealthbusinessFluconazolemedicine.drugThe Journal of Maternal-Fetal & Neonatal Medicine
researchProduct

Descriptive epidemiology of nasal carriage of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus among patients admitted to two he…

2014

Aim: To evaluate nasal carriage rate and variables associated with Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted in two healthcare facilities. Results: S. aureus was isolated from 159 (26%) of the enrolled patients. Methicillin-susceptible S. aureus was isolated from 150 (24.5%) patients, and MRSA was isolated from 9 (1.5%). Cancer and previous hospitalization were associated with a significantly higher frequency of nasal S. aureus carriage among the patients admitted to the general hospital and the nephrology department, respectively. MRSA isolates were heterogeneous with respect to their staphylococcal cassette chromosome mec element (SC…

Microbiology (medical)AdultMaleMethicillin-Resistant Staphylococcus aureusImmunologyMRSA epidemiology carriage AlgeriaNosemedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataMicrobiologyMicrobiologyMedicineNasal carriageHumansGeneral hospitalAgedPharmacologyNephrology departmentbusiness.industrySCCmecbiochemical phenomena metabolism and nutritionDescriptive epidemiologyMiddle AgedStaphylococcal Infectionsbacterial infections and mycosesMethicillin-resistant Staphylococcus aureusCarriageStaphylococcus aureusGenes BacterialAlgeriaFemaleMethicillin ResistancebusinessMicrobial drug resistance (Larchmont, N.Y.)
researchProduct